UNUM Therapeutics

Healthcare 📍 Cambridge, United States 👥 1001-5000 employees 💰 $89.3M raised 📅 Founded 2014

Unum Therapeutics uses proprietary T-cell engineering technology in combination with tumor-targeting antibodies to activate the body’s own immune system to fight cancer. Unum’s lead program, based on its Antibody-Coupled T-cell Receptor (ACTR) technology, is expected to enter Phase I clinical testing in the coming mont

🌐 Website in LinkedIn ← All Companies

📊 Company Overview

Sector

Healthcare

Country

United States

Employees

1001-5000

Total Raised · Venture

$89.3M

Founded

2014

Cloud

Unknown

Email

Mimecast

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider

Workspace	Mimecast
CDN	🔒 Subscribers only

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$11M – $27M / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms	🔒 Subscribers only
Analytics & CRM	🔒 Subscribers only
CMS / Platform	WordPress
Frontend Stack	🔒 Subscribers only

Detected from UNUM Therapeutics's public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

Peloton Interactive

1001-5000 ☁️ Vercel

1001-5000 ☁️ Unknown

1001-5000 ☁️ AWS

Data detected 2026-06-13 · Methodology · Suggest a correction